Table 1.
Strain | Acc. number | Serotype | Sequence type | Source | MIC CIP (μg/ml) | MIC NAL (μg/ml) | Antimicrobial resistance genes |
---|---|---|---|---|---|---|---|
SAL4629¥ | LILV00000000 | Enteritidis | 11 | Poultry | 1.0 | 32 | qnrB19* |
SAL4630¥ | LILU00000000 | Enteritidis | 11 | Poultry | 1.0 | 32 | qnrB19* |
SAL4674 | JWQH00000000 | Heidelberg | 15 | Kelp Gull | 0.5 | 16 | qnrB19* |
SAL4675 | JWQG00000000 | Heidelberg | 15 | Kelp Gull | 0.25 | > 32 | gyrA aa 83 F/S** |
SAL4676 | JWQF00000000 | Heidelberg | 15 | Kelp Gull | 0.25 | > 32 | gyrA aa 83 F/S** |
SAL4678 | JWQE00000000 | Heidelberg | 15 | Human | 0.5 | 16 | qnrB19* |
SAL4679 | JWQD00000000 | Heidelberg | 15 | Human | 0.5 | 32 | qnrB19* |
SAL4688 | JWRD00000000 | Senftenberg | 14 | Kelp Gull | 0.5 | 16 | qnrB19* |
CIP, ciprofloxacin; NAL, nalidixic acid.
Antimicrobial susceptibility ranges. CIP: susceptible (≤ 0.06); non-susceptible (0.06–1); resistant (≥ 1).
NAL: susceptible (≤ 16); resistant (≥ 32).
Acquired resistance genes searched using ResFinder tool, DTU. qnrB19: acquired antimicrobial resistance gene, plasmid borne.
Genomic gyrA gene: mutation in aminoacid 83.
Data published in Toro et al., 2016.